These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35646626)

  • 1. Differentiation of Meningiomas and Gliomas by Amide Proton Transfer Imaging: A Preliminary Study of Brain Tumour Infiltration.
    Zhang HW; Liu XL; Zhang HB; Li YQ; Wang YL; Feng YN; Deng K; Lei Y; Huang B; Lin F
    Front Oncol; 2022; 12():886968. PubMed ID: 35646626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging.
    Togao O; Hiwatashi A; Yamashita K; Kikuchi K; Keupp J; Yoshimoto K; Kuga D; Yoneyama M; Suzuki SO; Iwaki T; Takahashi M; Iihara K; Honda H
    Eur Radiol; 2017 Feb; 27(2):578-588. PubMed ID: 27003139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Grading of Glioma: combined diagnostic value of amide proton transfer weighted, arterial spin labeling and diffusion weighted magnetic resonance imaging.
    Kang XW; Xi YB; Liu TT; Wang N; Zhu YQ; Wang XR; Guo F
    BMC Med Imaging; 2020 May; 20(1):50. PubMed ID: 32408867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic performance between contrast enhancement, proton MR spectroscopy, and amide proton transfer imaging in patients with brain tumors.
    Sakata A; Fushimi Y; Okada T; Arakawa Y; Kunieda T; Minamiguchi S; Kido A; Sakashita N; Miyamoto S; Togashi K
    J Magn Reson Imaging; 2017 Sep; 46(3):732-739. PubMed ID: 28252822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of APT imaging in gliomas grading: A systematic review and meta-analysis.
    Sotirios B; Demetriou E; Topriceanu CC; Zakrzewska Z
    Eur J Radiol; 2020 Dec; 133():109353. PubMed ID: 33120241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of low- and high-grade pediatric gliomas with amide proton transfer imaging: added value beyond quantitative relaxation times.
    Zhang H; Yong X; Ma X; Zhao J; Shen Z; Chen X; Tian F; Chen W; Wu D; Zhang Y
    Eur Radiol; 2021 Dec; 31(12):9110-9119. PubMed ID: 34047848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amide Proton Transfer-weighted MRI combined with serum prostate-specific antigen levels for differentiating malignant prostate lesions from benign prostate lesions: a retrospective cohort study.
    Yang L; Wang L; Tan Y; Dan H; Xian P; Zhang Y; Tan Y; Lin M; Zhang J
    Cancer Imaging; 2023 Jan; 23(1):3. PubMed ID: 36611191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigated diagnostic value of synthetic relaxometry, three-dimensional pseudo-continuous arterial spin labelling and diffusion-weighted imaging in the grading of glioma.
    Ge X; Wang M; Ma H; Zhu K; Wei X; Li M; Zhai X; Shen Y; Huang X; Hou M; Liu W; Wang M; Wang X
    Magn Reson Imaging; 2022 Feb; 86():20-27. PubMed ID: 34808303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amide proton transfer imaging for differentiation of benign and atypical meningiomas.
    Joo B; Han K; Choi YS; Lee SK; Ahn SS; Chang JH; Kang SG; Kim SH; Zhou J
    Eur Radiol; 2018 Jan; 28(1):331-339. PubMed ID: 28687916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of magnetic resonance fingerprinting to differentiate grade I transitional and fibrous meningiomas from meningothelial meningiomas.
    Zhang R; Shen Y; Bai Y; Zhang X; Wei W; Lin R; Feng Q; Wang M; Zhang M; Nittka M; Koerzdoerfer G; Wang M
    Quant Imaging Med Surg; 2021 Apr; 11(4):1447-1457. PubMed ID: 33816181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of amide proton transfer imaging in maximizing tumor resection in malignant glioma: a possibility to take the place of
    Inoue A; Watanabe H; Kusakabe K; Nishikawa M; Shiraishi Y; Taniwaki M; Takimoto Y; Harada M; Furumochi T; Shigekawa S; Kitazawa R; Kido T; Ohnishi T; Kunieda T
    Neurosurg Rev; 2023 Nov; 46(1):294. PubMed ID: 37925381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DKI can distinguish high-grade gliomas from IDH1-mutant low-grade gliomas and correlate with their different nuclear-to-cytoplasm ratio: a localized biopsy-based study.
    Pang H; Dang X; Ren Y; Yao Z; Shen Y; Feng X; Wang Z
    Eur Radiol; 2024 Nov; 34(11):7539-7551. PubMed ID: 37962597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular MRI differentiation between primary central nervous system lymphomas and high-grade gliomas using endogenous protein-based amide proton transfer MR imaging at 3 Tesla.
    Jiang S; Yu H; Wang X; Lu S; Li Y; Feng L; Zhang Y; Heo HY; Lee DH; Zhou J; Wen Z
    Eur Radiol; 2016 Jan; 26(1):64-71. PubMed ID: 25925361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amide proton transfer imaging seems to provide higher diagnostic performance in post-treatment high-grade gliomas than methionine positron emission tomography.
    Park JE; Lee JY; Kim HS; Oh JY; Jung SC; Kim SJ; Keupp J; Oh M; Kim JS
    Eur Radiol; 2018 Aug; 28(8):3285-3295. PubMed ID: 29488086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grading of Gliomas by Using Radiomic Features on Multiple Magnetic Resonance Imaging (MRI) Sequences.
    Qin JB; Liu Z; Zhang H; Shen C; Wang XC; Tan Y; Wang S; Wu XF; Tian J
    Med Sci Monit; 2017 May; 23():2168-2178. PubMed ID: 28478462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evidence-based approach to evaluate the accuracy of amide proton transfer-weighted MRI in characterization of gliomas.
    Zhao J; Huang S; Xie H; Li W
    Medicine (Baltimore); 2019 Mar; 98(10):e14768. PubMed ID: 30855481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can amide proton transfer-weighted imaging differentiate tumor grade and predict Ki-67 proliferation status of meningioma?
    Yu H; Wen X; Wu P; Chen Y; Zou T; Wang X; Jiang S; Zhou J; Wen Z
    Eur Radiol; 2019 Oct; 29(10):5298-5306. PubMed ID: 30887206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting cancer malignancy and proliferation in glioma patients: intra-subject inter-metabolite correlation analyses using MRI and MRSI contrast scans.
    Su C; Li S; Chen X; Liu C; Shaghaghi M; Jiang J; Zhang S; Qin Y; Cai K
    Quant Imaging Med Surg; 2021 Jun; 11(6):2721-2732. PubMed ID: 34079736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical exchange saturation transfer (CEST) signal intensity at 7T MRI of WHO IV° gliomas is dependent on the anatomic location.
    Dreher C; Oberhollenzer J; Meissner JE; Windschuh J; Schuenke P; Regnery S; Sahm F; Bickelhaupt S; Bendszus M; Wick W; Unterberg A; Zaiss M; Bachert P; Ladd ME; Schlemmer HP; Radbruch A; Paech D
    J Magn Reson Imaging; 2019 Mar; 49(3):777-785. PubMed ID: 30133046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intergrating conventional MRI, texture analysis of dynamic contrast-enhanced MRI, and susceptibility weighted imaging for glioma grading.
    Su CQ; Lu SS; Han QY; Zhou MD; Hong XN
    Acta Radiol; 2019 Jun; 60(6):777-787. PubMed ID: 30244590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.